CYTOKINETICS, INCORPORATED Operating Leases, Future Minimum Payments, Due in Two Years
CYTOKINETICS, INCORPORATED (CYTK) had Operating Leases, Future Minimum Payments, Due in Two Years of $4.80 million as of 2018-12-31, per its 10-K filed 2020-03-04.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-03-04
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $4.80M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $4.68M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $1.86M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $3.63M.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $4.80M 10-K · filed 2020-03-04 |
| 2017-12-31 | $4.68M 10-K · filed 2018-03-05 |
| 2016-12-31 | $1.86M 10-K · filed 2017-03-06 |
| 2015-12-31 | $3.63M 10-K · filed 2016-03-03 |
| 2014-12-31 | $3.50M 10-K · filed 2015-03-06 |
| 2013-12-31 | $3.47M 10-K · filed 2014-03-07 |
| 2012-12-31 | $3.36M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |